Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Benavides M, Lotz JP, Misset JL, de Vassal F, Tapiero H, et al. Machover D, et al. Among authors: misset jl. Eur J Haematol Suppl. 1987;47:33-42. doi: 10.1111/j.1600-0609.1987.tb00020.x. Eur J Haematol Suppl. 1987. PMID: 3471523 No abstract available.
Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Ribaud P, Schwarzenberg L, et al. Machover D, et al. Among authors: misset jl. Cancer Treat Rep. 1984 Jun;68(6):881-6. Cancer Treat Rep. 1984. PMID: 6587933
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.
Mathé G, Bayssas M, Gouveia J, Dantchev D, Ribaud P, Machover D, Misset JL, Schwarzenberg L, Jasmin C, Hayat M. Mathé G, et al. Among authors: misset jl. Cancer Chemother Pharmacol. 1978;1(4):259-62. doi: 10.1007/BF00257160. Cancer Chemother Pharmacol. 1978. PMID: 373923 Clinical Trial.
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
Misset JL, Mathé G, Gastiaburu J, Goutner A, Dorval TI, Gouveia J, Hayat M, Jasmin C, Schwarzenberg L, Machover D, Ribaud P, de Vassal F, Horoszewicz JP. Misset JL, et al. Biomed Pharmacother. 1982;36(3):167-70. Biomed Pharmacother. 1982. PMID: 6758874 Clinical Trial. French.
284 results